Regencell Bioscience (RGC) had the highest return in December 2025 by a large-cap US stock, returning 82.5%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Regencell Bioscience (RGC) | December 2025 | 82.45% |
Planet Labs PBC (PL) | December 2025 | 70% |
Rocket Lab USA (RKLB) | December 2025 | 69.53% |
EchoStar (SATS) | December 2025 | 52.52% |
Applied Opt (AAOI) | December 2025 | 35.22% |
Ast Spacemobile (ASTS) | December 2025 | 33.63% |
MongoDB (MDB) | December 2025 | 28.57% |
Carnival Plc ADS (CUK) | December 2025 | 27.17% |
Alcoa (AA) | December 2025 | 27.07% |
Arrowhead Pharmaceuticals (ARWR) | December 2025 | 26.77% |
Vicor (VICR) | December 2025 | 25.09% |
Elbit Systems (ESLT) | December 2025 | 24.31% |
Micron Technology (MU) | December 2025 | 22.92% |
Sitime (SITM) | December 2025 | 21.95% |
Axsome Therapeutics (AXSM) | December 2025 | 21.76% |
Dollar General (DG) | December 2025 | 21.64% |
Warner Bros Discovery (WBD) | December 2025 | 21.02% |
Microchip Technology (MCHP) | December 2025 | 20.5% |
UBS (UBS) | December 2025 | 20.38% |
Ciena (CIEN) | December 2025 | 20.25% |
Southwest Airlines (LUV) | December 2025 | 20.21% |
Medline Inc Class A Common Stock (MDLN) | December 2025 | 20% |
Carnival (CCL) | December 2025 | 19.11% |
Rivian Automotive (RIVN) | December 2025 | 19.09% |
TFI International (TFII) | December 2025 | 18.84% |
Large-cap stocks are treated as having a market cap of $10B+.